Tolerance of formulas containing prebiotics in healthy, term infants

Timberly Williams1, Yong Choe, Pamela Price

  • 1Abbott Nutrition, Columbus, OH.

Insights

Infant formula with 4 g galacto-oligosaccharides (GOS)/L showed good gastrointestinal tolerance, similar to human milk, in healthy newborns. Formula with 8 g GOS/L resulted in more watery stools compared to control formula.

Area of Science:

  • Pediatrics
  • Nutritional Science
  • Gastroenterology

Background:

  • Infant gastrointestinal tolerance is crucial for proper development.
  • Galacto-oligosaccharides (GOS) are prebiotics that may influence infant gut health.
  • Understanding the impact of different GOS levels in infant formula is important for optimizing infant nutrition.

Purpose of the Study:

  • To compare the gastrointestinal tolerance of infant formulas with two different levels of galacto-oligosaccharides (GOS) against a control formula (CF) and human milk.
  • To evaluate the effects of GOS supplementation on stool consistency and other tolerance markers in healthy term infants.

Main Methods:

  • A double-blind, randomized, multicenter study involving 180 healthy, full-term infants.
  • Infants were fed formula with 4 g GOS/L (EF4), 8 g GOS/L (EF8), or a control formula (CF) until 119 days of life.
  • Stool consistency was assessed daily using a 5-point scale, and other tolerance parameters were recorded.

Main Results:

  • The control formula group exhibited higher mean stool consistency scores compared to EF8 and human milk groups throughout the study.
  • A higher percentage of watery stools was observed in the EF8 group versus the CF group during the first 14 days of life.
  • The human milk group showed a significantly lower percentage of feedings with spit-up or vomiting compared to EF8 and CF groups.

Conclusions:

  • Milk-based term infant formula supplemented with 4 g GOS/L demonstrated good gastrointestinal tolerance in newborns.
  • Stool consistency and other tolerance measures were favorable in infants fed formula with 4 g GOS/L.
  • Further research may be needed to fully elucidate the effects of higher GOS concentrations on infant tolerance.
Abstract

Related Concept Videos

Probiotics01:22

Probiotics

Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
289
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
60
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
1.0K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
954
Microbes in Food Production01:29

Microbes in Food Production

Microbial fermentation is central to food biotechnology, enhancing flavor, texture, preservation, and stability. Fermentative microorganisms metabolize carbohydrates into organic acids, alcohols, and other metabolites that inhibit spoilage organisms and improve digestibility while contributing distinctive sensory qualities.In baking, amylases naturally present in flour hydrolyze starch into monosaccharides such as glucose, which Saccharomyces cerevisiae ferments anaerobically. Through...
390
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
62